ChemicalBook Chinese Germany Japanese Korean

上海瀚香生物科技有限公司 Company Information
Company Name:    ShangHai Biochempartner Co.,Ltd
Tel:    177-54423994
Email:    2853530910@QQ.com
Nationality:    China
WebSite:    www.biochempartner.com
Product List:    8000
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Product List
1-Piperidinamine, N-hydroxy-N-nitroso- 56329-24-9
Ozoralizumab 1167985-17-2
Blosozumab 1132758-87-2
Sirukumab 1194585-53-9
Enoticumab 1192578-27-0
Vandortuzumab Vedotin 1471985-92-8
Afasevikumab 1589503-30-9
Amivantamab 2171511-58-1
JQKD-82 2410512-38-6
ML339 2579689-83-9
INE963 2640567-43-5
OTX 008 286936-40-1
Enoblituzumab 1353485-38-7
SBI-425 1451272-71-1
2,4-Dichlorophenoxyacetyl chloride 774-74-3
Mc-Val-Ala-PAB-PNP 1639939-40-4
Tregalizumab 1207446-68-1
Flanvotumab 1188277-05-5
Clazakizumab 1236278-28-6
Tafasitamab 1422527-84-1
AZD-1940 881413-29-2
Bocidelpar 2095128-20-2
NCC007 2342583-66-6
Lirilumab 1000676-41-4
Sigma-1 receptor antagonist 2 1639220-15-7
Onartuzumab 1133766-06-9
Indatuximab Ravtansine 1238517-16-2
Quilizumab 1228538-47-3
Tesidolumab 1531594-08-7
Rovalpituzumab 1613313-01-1
Xentuzumab 1417158-65-6
AZ32 2288709-96-4
JYN42346 1903742-34-6
TH5427 2253744-56-6
MRTX1719 2630904-45-7
Zunsemetinib 1640282-42-3
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione 1380532-27-3
Crenezumab 1095207-05-8
Tabalumab 1143503-67-6
Fasinumab 1190239-42-9
Lacutamab 2187368-16-5
Indusatumab Vedotin 1514889-12-3
Tisotumab 1418628-81-5
Olendalizumab 1337966-73-0
NCGC00378430 920650-00-6
Apostatin-1 2559703-06-7
Ublituximab 1174014-05-1
Narnatumab 1188275-92-4
Demcizumab 1243262-17-0
Imgatuzumab 959963-46-3
Lokivetmab 1533403-95-0
Rinucumab 1569263-06-4
Tilavonemab 2096513-89-0
GI 181771 305366-98-7
Ponezumab 1178862-65-1
Caplacizumab 915810-67-2
Actoxumab 1245634-25-6
Refanezumab 1233953-61-1
SUC-ALA-ALA-PRO-PHE-PNA 107409-54-1
Ro60-0175 169675-08-5
AMG-131 315224-26-1
Boc-Val-Ala-PAB-PNP 1884578-00-0
Ficlatuzumab 1174900-84-5
Vatelizumab 1238217-55-4
Futuximab 1310460-85-5
Andecaliximab 1518996-49-0
Nemolizumab 1476039-58-3
Satralizumab 1535963-91-7
Blontuvetmab 1608112-78-2
FTO-IN-3 2585198-87-2
BioE-1197 1268863-69-9
SR1664 1338259-05-4
Patritumab 1262787-83-6
Vesencumab 1205533-60-3
Pateclizumab 1202526-59-7
Duligotuzumab 1314238-96-4
Ligelizumab 1322627-61-1
Evinacumab 1446419-85-7
Ensitrelvir fumarate 2757470-18-9
RY785 1393748-80-5
Urelumab 934823-49-1
Erucin 4430-36-8
Radretumab 1253180-81-2
Inclacumab 1256258-86-2
Bezlotoxumab 1246264-45-8
Dectrekumab 1528523-94-5
Ifabotuzumab 1234137-51-9
Mirvetuximab 1453084-36-0
SCD1 inhibitor-3 1282606-48-7
2,4-Imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]- 877176-23-3
YM150 365462-23-3
Biotinyl Cystamine 128915-82-2
Risankizumab 1612838-76-2
Solitomab 1005198-65-1
Isatuximab 1461640-62-9
Cabiralizumab 1613144-80-1
Tamtuvetmab 1608122-71-9
GSK251 2125968-05-8
YTX-465 2225824-53-1
(R)-GSK-3685032 2170140-50-6
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2007©  ChemicalBook. All rights reserved.